Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Journal of Medicinal Chemistry
|
February 10, 2009
Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists
Guo Li, Lindsey C Aschenbach, Jianyang Chen, et al.
Journal of Medicinal Chemistry
|
December 29, 2023
Molecular Pharmacology Profiling of Phenylfentanil and Its Analogues to Understand the Putative Involvement of an Adrenergic Mechanism in Fentanyl-Induced Respiratory Depression
Mengchu Li, Piyusha P Pagare, Hongguang Ma, et al.
Journal of Medicinal Chemistry
|
January 5, 2019
Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands
Yi Zheng, Samuel Obeng, Huiqun Wang, et al.
ACS Chemical Neuroscience
|
November 30, 2022
Characterization of a Potential KOR/DOR Dual Agonist with No Apparent Abuse Liability via a Complementary Structure-Activity Relationship Study on Nalfurafine Analogues
Mengchu Li, David L Stevens, Michelle Arriaga, et al.
ACS Chemical Neuroscience
|
June 9, 2016
6β-N-Heterocyclic Substituted Naltrexamine Derivative BNAP: A Peripherally Selective Mixed MOR/KOR Ligand
Dwight A Williams, Yi Zheng, Bethany G David, et al.
ACS Pharmacology & Translational Science
|
December 19, 2024
Discovery of 6α-Thiazolylcarboxamidonaltrexamine Derivative (NTZ) as a Potent and Central Nervous System Penetrant Opioid Receptor Modulator with Drug-like Properties for Potential Treatment of Opioid Use Disorder
Boshi Huang, Hongguang Ma, Piyusha P Pagare, et al.
International Journal of Radiation Biology
|
March 6, 2010
Double-strand break induction and repair in V79-4 hamster cells: the role of core ionisations, as probed by ultrasoft X-rays
Marie-Anne Hervé du Penhoat, Anne Eschenbrenner, François Abel, et al.
Journal of Medicinal Chemistry
|
May 30, 2024
Systematic Structure-Activity Relationship Study of Nalfurafine Analogues toward Development of Potentially Nonaddictive Pain Management Treatments
Celsey M St Onge, Piyusha P Pagare, Yi Zheng, et al.
ACS Chemical Neuroscience
|
February 14, 2019
Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment
Samuel Obeng, Abdulmajeed Jali, Yi Zheng, et al.
Journal of Medicinal Chemistry
|
November 3, 2012
Design, synthesis, and biological evaluation of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives as peripheral selective μ opioid receptor Agents
Yunyun Yuan, Orgil Elbegdorj, Jianyang Chen, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Journal of Medicinal Chemistry
|
February 10, 2009
Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists
Guo Li, Lindsey C Aschenbach, Jianyang Chen, et al.
Journal of Medicinal Chemistry
|
December 29, 2023
Molecular Pharmacology Profiling of Phenylfentanil and Its Analogues to Understand the Putative Involvement of an Adrenergic Mechanism in Fentanyl-Induced Respiratory Depression
Mengchu Li, Piyusha P Pagare, Hongguang Ma, et al.
Journal of Medicinal Chemistry
|
January 5, 2019
Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands
Yi Zheng, Samuel Obeng, Huiqun Wang, et al.
ACS Chemical Neuroscience
|
November 30, 2022
Characterization of a Potential KOR/DOR Dual Agonist with No Apparent Abuse Liability via a Complementary Structure-Activity Relationship Study on Nalfurafine Analogues
Mengchu Li, David L Stevens, Michelle Arriaga, et al.
ACS Chemical Neuroscience
|
June 9, 2016
6β-N-Heterocyclic Substituted Naltrexamine Derivative BNAP: A Peripherally Selective Mixed MOR/KOR Ligand
Dwight A Williams, Yi Zheng, Bethany G David, et al.
ACS Pharmacology & Translational Science
|
December 19, 2024
Discovery of 6α-Thiazolylcarboxamidonaltrexamine Derivative (NTZ) as a Potent and Central Nervous System Penetrant Opioid Receptor Modulator with Drug-like Properties for Potential Treatment of Opioid Use Disorder
Boshi Huang, Hongguang Ma, Piyusha P Pagare, et al.
International Journal of Radiation Biology
|
March 6, 2010
Double-strand break induction and repair in V79-4 hamster cells: the role of core ionisations, as probed by ultrasoft X-rays
Marie-Anne Hervé du Penhoat, Anne Eschenbrenner, François Abel, et al.
Journal of Medicinal Chemistry
|
May 30, 2024
Systematic Structure-Activity Relationship Study of Nalfurafine Analogues toward Development of Potentially Nonaddictive Pain Management Treatments
Celsey M St Onge, Piyusha P Pagare, Yi Zheng, et al.
ACS Chemical Neuroscience
|
February 14, 2019
Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment
Samuel Obeng, Abdulmajeed Jali, Yi Zheng, et al.
Journal of Medicinal Chemistry
|
November 3, 2012
Design, synthesis, and biological evaluation of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives as peripheral selective μ opioid receptor Agents
Yunyun Yuan, Orgil Elbegdorj, Jianyang Chen, et al.
Page
of 6